Matthias Pinter

7PUBLICATIONS
64CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Tumour immunologyCardiology (incl. cardiovascular diseases)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Nov 04, 2024
Atezolizumab/bevacizumab and lenvatinib for hepatocellular carcinoma: A comparative analysis in a European real-world cohort.

Tiago de Castro, Sabrina Welland, Leonie Jochheim

|Oct 27, 2023
Efficacy and safety of atezolizumab/bevacizumab in patients with HCC after prior systemic therapy: A global, observational study.

Vincent Joerg, Bernhard Scheiner, Antonio D Alessio

|Mar 21, 2022
Preliminary evidence of safety and tolerability of atezolizumab plus bevacizumab in patients with hepatocellular carcinoma and Child-Pugh A and B cirrhosis: A real-world study.

Antonio D'Alessio, Claudia Angela Maria Fulgenzi, Naoshi Nishida

|Sep 24, 2021
Morphometric Analysis of Mast Cells in Tumor Predicts Recurrence of Hepatocellular Carcinoma After Liver Transplantation.

Nataliya Rohr-Udilova, Kaoru Tsuchiya, Gerald Timelthaler

|Aug 13, 2021
Regorafenib Efficacy After Sorafenib in Patients With Recurrent Hepatocellular Carcinoma After Liver Transplantation: A Retrospective Study.

Massimo Iavarone, Federica Invernizzi, Tommy Ivanics

|Jul 05, 2021
COVID-19-Related Downscaling of In-Hospital Liver Care Decreased Patient Satisfaction and Increased Liver-Related Mortality.

Lukas Hartl, Georg Semmler, Benedikt Silvester Hofer

Pageof 2

Frequent Collaborators

4 joint publications

Bernhard Scheiner

2 joint publications

Dominik Bettinger

2 joint publications

Arndt Weinmann

2 joint publications

Yi-Hsiang Huang